Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors — SMART  

Hematopoietic Stem Cell Mobilization Clinical Trial

Official title: Non-interventional, Prospective, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Healthy Unrelated Stem Cell Donors Undergoing Peripheral Blood Progenitor Cell Mobilization

Status Active, not recruiting

Clinical Trial Summary

Data collection on the safety and efficacy of Zarzio® / Filgrastim HEXAL® in adult healthy unrelated stem cell donors undergoing peripheral blood progenitor cell mobilization.

Clinical Trial Description

This will be a prospective, non-interventional long term data collection study. Adult healthy unrelated stem cell donors receiving Sandoz' filgrastim according to the stem cell mobilization protocols of the respective apheresis centers will be monitored for safety and efficacy during the mobilization period, and a systematic safety data follow-up will be implemented for up to 10 years after mobilization. ;

Related Conditions & MeSH terms

• Hematopoietic Stem Cell Mobilization

• NCT number: NCT01766934
• Study type: Observational
• Source: Sandoz
• Status: Active, not recruiting
• Start date: May 2011
• Completion date: August 16, 2024